Treatment of Asymptomatic 70% Left Carotid Stenosis
For asymptomatic 70% carotid stenosis, routine revascularization is NOT recommended—optimal medical therapy (OMT) alone is the treatment of choice based on the most recent 2024 ESC guidelines. 1
Primary Recommendation
The 2024 ESC Guidelines explicitly state that in asymptomatic patients with ICA stenosis, in the absence of high-risk features and with a life expectancy <5 years, routine revascularization is not recommended (Class III A recommendation) 1. This represents the highest level of evidence against intervention in your scenario.
Medical Management: The Cornerstone
All patients with asymptomatic carotid stenosis must receive aggressive optimal medical therapy, which includes 1:
- Intensive lipid-lowering therapy (ILT): Target >50% LDL-C reduction and LDL-C <1.4 mmol/L (55 mg/dL) with high-dose statin therapy
- Antiplatelet therapy: Long-term aspirin or clopidogrel (75 mg daily)
- Blood pressure control: Strict management with antihypertensive agents
- Diabetes management: If applicable
- Lifestyle modifications: Smoking cessation, diet, exercise
The 2024 guidelines emphasize that once-yearly follow-up is recommended to check for cardiovascular risk factors and treatment compliance 1.
When to Consider Revascularization
Revascularization (CEA or CAS) should only be considered in highly selected asymptomatic patients if ALL of the following criteria are met 1, 2:
- Life expectancy >5 years
- High-risk features present (plaque characteristics suggesting vulnerability)
- Perioperative stroke/death risk <3%
- Patient is fit for and willing to undergo intervention
The 2014 AHA guidelines note that CEA might be reasonable for asymptomatic stenosis >70% if perioperative risk is <3%, but emphasize this effectiveness compared to contemporary best medical management alone is not well established 2.
Critical Nuance: The Evidence Has Evolved
The paradigm has shifted dramatically—older trials supporting revascularization for asymptomatic stenosis were conducted before modern intensive medical therapy became standard. The annual stroke risk with contemporary OMT has dropped to approximately 1% per year 3, making the absolute benefit of revascularization marginal at best.
Surveillance Protocol
Duplex ultrasound surveillance is recommended annually to assess 1:
- Progression or regression of stenosis
- Response to medical therapy
- Development of high-risk features that might change management
- Contralateral disease
Common Pitfalls to Avoid
- Do not automatically refer for revascularization based solely on stenosis severity—the 70% threshold from older guidelines no longer applies universally to asymptomatic patients
- Do not underestimate the power of modern medical therapy—intensive statin therapy, strict BP control, and antiplatelet agents have fundamentally changed outcomes
- Do not use ECST method for stenosis measurement—use NASCET method or its non-invasive equivalent 1
- Ensure the stenosis is truly asymptomatic—carefully exclude subtle TIAs, amaurosis fugax, or cognitive symptoms that would reclassify this as symptomatic disease
If Symptoms Develop
Should the patient develop ANY ipsilateral neurological symptoms (TIA, stroke, amaurosis fugax), management changes completely: CEA is recommended for symptomatic 70-99% stenosis with documented perioperative risk <6%, ideally performed within 14 days 1.